Equities Analysts Issue Forecasts for Harpoon Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:HARP)

Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) – Equities researchers at HC Wainwright issued their FY2027 EPS estimates for Harpoon Therapeutics in a research note issued to investors on Wednesday, March 29th. HC Wainwright analyst S. Ramakanth expects that the company will earn $0.23 per share for the year. HC Wainwright has a “Buy” rating […]

Related Keywords

Ronald Hunt ,Nasdaq ,Harpoon Therapeutics Company Profile ,Blackrock Inc ,Renaissance Technologies ,Dimensional Fund Advisors ,Vanguard Group Inc ,Harpoon Therapeutics Inc ,Sequoia Financial Advisors ,Harpoon Therapeutics ,Get Rating ,Harpoon Therapeutic ,Truist Financial ,Director Ronald Hunt ,Fund Advisors ,Financial Advisors ,Activating Construct ,Harpoon Therapeutics Daily ,Nasdaq Harp ,Sharp ,Medical ,Earnings Estimates ,Hc Wainwright ,